HGH Frag 176-191

Also known as: AOD-9402, GH Frag, Lipolytic GH fragment

Truncated C-terminal fragment of human growth hormone (residues 176-191). Selectively activates lipolysis without the metabolic side effects of full-length GH (no IGF-1 elevation, no insulin resistance).

Typical dose: 250 mcg – 500 mcg
Frequency: once daily
Route: Subcutaneous
Half-life: 30 minutes
Routes: Subcutaneous
Status: Research chemical: not FDA approved

Track your HGH Frag 176-191 protocol in Vial →

Benefits

Targeted fat loss
Visceral fat reduction
No GH side effects
No appetite stimulation

Dosing

A common research range for HGH Frag 176-191 is 250 mcg to 500 mcg once daily. Inject AM on empty stomach for fat-burning synergy. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Reconstitution

A typical reconstitution for HGH Frag 176-191 is 5 mg of peptide in 2 mL of bacteriostatic water, giving roughly 2.5 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.

Half-life

HGH Frag 176-191 has an approximate half-life of 30 minutes. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

2-8°C post-reconstitution.

Reported side effects

Injection site irritation
Mild lethargy

Contraindications

Active malignancy

Commonly stacked with

AOD-9604 CJC-1295 (no DAC)Ipamorelin

Track HGH Frag 176-191 with Vial

Vial logs every HGH Frag 176-191 dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. HGH Frag 176-191 is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.